Constanze Schmidt - Publications

Affiliations: 
2008- Georg-August-Universität Göttingen, Göttingen, Niedersachsen, Germany 

17/85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Wiedmann F, Kraft M, Kallenberger S, Büscher A, Paasche A, Blochberger PL, Seeger T, Jávorszky N, Warnecke G, Arif R, Kremer J, Karck M, Frey N, Schmidt C. MicroRNAs Regulate TASK-1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation. Journal of the American Heart Association. 11: e023472. PMID 35301863 DOI: 10.1161/JAHA.121.023472  0.686
2021 Wiedmann F, Beyersdorf C, Zhou XB, Kraft M, Paasche A, Jávorszky N, Rinné S, Sutanto H, Büscher A, Foerster KI, Blank A, El-Battrawy I, Li X, Lang S, Tochtermann U, ... ... Schmidt C, et al. Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy. Cardiovascular Research. PMID 34028533 DOI: 10.1093/cvr/cvab177  0.706
2020 Schmidt C, Benda S, Kraft P, Wiedmann F, Pleger S, Büscher A, Thomas D, Wachter R, Schmid C, Eils R, Katus HA, Kallenberger SM. Prospective multicentric validation of a novel prediction model for paroxysmal atrial fibrillation. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. PMID 33211156 DOI: 10.1007/s00392-020-01773-z  0.694
2020 Schmidt C, Kallenberger SM. Ageing is associated with increased variability of cellular reprogramming and wound healing. Cardiovascular Research. 116: e171-e174. PMID 33096562 DOI: 10.1093/cvr/cvaa294  0.641
2019 Kallenberger SM, Schmidt C. Forecasting the development of acute kidney injury using a recurrent neural network. Cardiovascular Research. PMID 31697360 DOI: 10.1093/cvr/cvz279  0.641
2019 Schmidt C, Wiedmann F, Beyersdorf C, Zhao Z, El-Battrawy I, Kraft M, Lang S, Szabo G, Karck M, Zhou X, Borggrefe M, Thomas D, Haefeli WE, Decher N, Katus H. 1206Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation European Heart Journal. 40. DOI: 10.1093/eurheartj/ehz748.0036  0.31
2017 Schmidt C, Wiedmann F, Kallenberger SM, Ratte A, Schulte JS, Scholz B, Müller FU, Voigt N, Zafeiriou MP, Ehrlich JR, Tochtermann U, Veres G, Ruhparwar A, Karck M, Katus HA, et al. Stretch-activated two-pore-domain (K2P) potassium channels in the heart: Focus on atrial fibrillation and heart failure. Progress in Biophysics and Molecular Biology. PMID 28526353 DOI: 10.1016/j.pbiomolbio.2017.05.004  0.707
2017 Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, et al. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. European Heart Journal. PMID 28057773 DOI: 10.1093/Eurheartj/Ehw559  0.713
2016 Kallenberger SM, Schmid C, Wiedmann F, Mereles D, Katus HA, Thomas D, Schmidt C. A Simple, Non-Invasive Score to Predict Paroxysmal Atrial Fibrillation. Plos One. 11: e0163621. PMID 27680490 DOI: 10.1371/journal.pone.0163621  0.688
2016 Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, et al. Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation". Circulation. 133: e440-1. PMID 26976923 DOI: 10.1161/CIRCULATIONAHA.115.020662  0.696
2015 Glasscock E, Voigt N, McCauley MD, Sun Q, Li N, Chiang DY, Zhou XB, Molina CE, Thomas D, Schmidt C, Skapura DG, Noebels JL, Dobrev D, Wehrens XH. Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation. Basic Research in Cardiology. 110: 505. PMID 26162324 DOI: 10.1007/S00395-015-0505-6  0.304
2015 Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, et al. Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients with Chronic Atrial Fibrillation. Circulation. PMID 25951834 DOI: 10.1161/CIRCULATIONAHA.114.012657  0.704
2014 Kallenberger SM, Schmidt C, Dechent P, Forster C, von Steinbüchel N, Wüstenberg T, Strasburger H. Separating fusion from rivalry. Plos One. 9: e103037. PMID 25054904 DOI: 10.1371/Journal.Pone.0103037  0.664
2014 Schmidt C, Wiedmann F, Langer C, Tristram F, Anand P, Wenzel W, Lugenbiel P, Schweizer PA, Katus HA, Thomas D. Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 11: 1798-805. PMID 24952150 DOI: 10.1016/j.hrthm.2014.06.020  0.307
2014 Schmidt C, Wiedmann F, Tristram F, Anand P, Wenzel W, Lugenbiel P, Schweizer PA, Katus HA, Thomas D. Cardiac expression and atrial fibrillation-associated remodeling of Kâ‚‚p2.1 (TREK-1) K⁺ channels in a porcine model. Life Sciences. 97: 107-15. PMID 24345461 DOI: 10.1016/j.lfs.2013.12.006  0.303
2010 Kallenberger S, Schmidt C, Wustenberg T, Strasburger H. Visual Fusion and Binocular Rivalry in Cortical Visual Areas Journal of Vision. 10: 360-360. DOI: 10.1167/10.7.360  0.695
2003 Carmesin HO, Kallenberger S, Schmidt C. [Shutter-glasses haploscope with eye-tracking control for fusion therapy]. Klinische MonatsbläTter FüR Augenheilkunde. 220: 629-33. PMID 14533062 DOI: 10.1055/s-2003-42810  0.648
Low-probability matches (unlikely to be authored by this person)
2018 Wiedmann F, Schulte JS, Gomes B, Zafeiriou MP, Ratte A, Rathjens F, Fehrmann E, Scholz B, Voigt N, Müller FU, Thomas D, Katus HA, Schmidt C. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K) channels in murine disease models: focus on TASK-1. Basic Research in Cardiology. 113: 27. PMID 29881975 DOI: 10.1007/s00395-018-0687-9  0.289
2021 Jakob D, Klesen A, Allegrini B, Darkow E, Aria D, Emig R, Chica AS, Rog-Zielinska EA, Guth T, Beyersdorf F, Kari FA, Proksch S, Hatem SN, Karck M, Künzel SR, ... ... Schmidt C, et al. Piezo1 and BK channels in human atrial fibroblasts: Interplay and remodelling in atrial fibrillation. Journal of Molecular and Cellular Cardiology. PMID 33974928 DOI: 10.1016/j.yjmcc.2021.05.002  0.285
2021 Wiedmann F, Frey N, Schmidt C. Two-Pore-Domain Potassium (K-) Channels: Cardiac Expression Patterns and Disease-Specific Remodelling Processes. Cells. 10. PMID 34831137 DOI: 10.3390/cells10112914  0.284
2019 Schmidt C, Wiedmann F, Beyersdorf C, Zhao Z, El-Battrawy I, Lan H, Szabo G, Li X, Lang S, Korkmaz-Icöz S, Rapti K, Jungmann A, Ratte A, Müller OJ, Karck M, et al. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K Channel-Related Acid-Sensitive K Channel-1) (K3.1) K Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling. Circulation. Arrhythmia and Electrophysiology. 12: e007465. PMID 31514528 DOI: 10.1161/Circep.119.007465  0.282
2020 Wiedmann F, Beyersdorf C, Zhou X, Büscher A, Kraft M, Nietfeld J, Walz TP, Unger LA, Loewe A, Schmack B, Ruhparwar A, Karck M, Thomas D, Borggrefe M, Seemann G, ... ... Schmidt C, et al. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model. Journal of the American Heart Association. e015751. PMID 32390491 DOI: 10.1161/JAHA.119.015751  0.28
2019 Ratte A, Wiedmann F, Kraft M, Katus HA, Schmidt C. Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels. Frontiers in Pharmacology. 10: 1367. PMID 32038227 DOI: 10.3389/fphar.2019.01367  0.273
2014 Schmidt C, Wiedmann F, Schweizer PA, Katus HA, Thomas D. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept. European Journal of Pharmacology. 738: 250-5. PMID 24927994 DOI: 10.1016/j.ejphar.2014.05.056  0.272
2018 Schmidt C, Wiedmann F, Gaubatz AR, Ratte A, Katus HA, Thomas D. New targets for old drugs: cardiac glycosides inhibit atrial-specific K2P3.1 (TASK-1) channels. The Journal of Pharmacology and Experimental Therapeutics. PMID 29643254 DOI: 10.1124/jpet.118.247692  0.266
2021 Kraft M, Büscher A, Wiedmann F, L'hoste Y, Haefeli WE, Frey N, Katus HA, Schmidt C. Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option. Frontiers in Pharmacology. 12: 638445. PMID 33897427 DOI: 10.3389/fphar.2021.638445  0.262
2011 Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D. The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vascular Health and Risk Management. 7: 193-202. PMID 21490945 DOI: 10.2147/VHRM.S10758  0.261
2020 Wiedmann F, Schlund D, Kraft M, Nietfeld J, Katus HA, Schmidt C, Thomas D. Electrophysiological effects of non-vitamin K antagonist oral anticoagulants on atrial repolarizing potassium channels. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 32676673 DOI: 10.1093/europace/euaa129  0.26
2021 Darkow E, Nguyen TT, Stolina M, Kari FA, Schmidt C, Wiedmann F, Baczkó I, Kohl P, Rajamani S, Ravens U, Peyronnet R. Small Conductance Ca-Activated K (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation and Heart Failure Tissue. Frontiers in Physiology. 12: 650964. PMID 33868017 DOI: 10.3389/fphys.2021.650964  0.257
2020 Wiedmann F, Beyersdorf C, Zhou XB, Kraft M, Foerster KI, El-Battrawy I, Lang S, Borggrefe M, Haefeli WE, Frey N, Schmidt C. The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model. Frontiers in Physiology. 11: 629421. PMID 33551849 DOI: 10.3389/fphys.2020.629421  0.257
2020 Fakuade FE, Steckmeister V, Seibertz F, Gronwald J, Kestel S, Menzel J, Pronto JRD, Taha K, Haghighi F, Kensah G, Pearman CM, Wiedmann F, Teske AJ, Schmidt C, Dibb KM, et al. Altered Atrial Cytosolic Calcium Handling Contributes to the Development of Postoperative Atrial Fibrillation. Cardiovascular Research. PMID 32520995 DOI: 10.1093/cvr/cvaa162  0.249
2024 Paasche A, Wiedmann F, Kraft M, Seibertz F, Herlt V, Blochberger PL, Jávorszky N, Beck M, Weirauch L, Seeger T, Blank A, Haefeli WE, Arif R, Meyer AL, Warnecke G, ... ... Schmidt C, et al. Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes. Basic Research in Cardiology. PMID 38170280 DOI: 10.1007/s00395-023-01022-0  0.245
2020 Wiedmann F, Rinné S, Donner B, Decher N, Katus HA, Schmidt C. Mechanosensitive TREK-1 two-pore-domain potassium (K) channels in the cardiovascular system. Progress in Biophysics and Molecular Biology. PMID 32553901 DOI: 10.1016/j.pbiomolbio.2020.05.007  0.243
2012 Schmidt C, Wiedmann F, Schweizer PA, Katus HA, Thomas D. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential]. Deutsche Medizinische Wochenschrift (1946). 137: 1654-8. PMID 22875694 DOI: 10.1055/s-0032-1305216  0.242
2016 Wiedmann F, Schmidt C, Lugenbiel P, Staudacher I, Rahm AK, Seyler C, Schweizer PA, Katus HA, Thomas D. Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular system. Clinical Science (London, England : 1979). 130: 643-50. PMID 26993052 DOI: 10.1042/CS20150533  0.236
2023 Wiedmann F, Paasche A, Nietfeld J, Kraft M, Meyer AL, Warnecke G, Karck M, Frey N, Schmidt C. Activation of neurokinin-III receptors modulates human atrial TASK-1 currents. Journal of Molecular and Cellular Cardiology. 184: 26-36. PMID 37793594 DOI: 10.1016/j.yjmcc.2023.09.010  0.235
2012 Schmidt C, Wiedmann F, Schweizer PA, Becker R, Katus HA, Thomas D. Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 1003-16. PMID 22790794 DOI: 10.1007/s00210-012-0780-9  0.227
2013 Li J, Seyler C, Wiedmann F, Schmidt C, Schweizer PA, Becker R, Katus HA, Thomas D. Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy. Cardiovascular Research. 98: 496-503. PMID 23447643 DOI: 10.1093/cvr/cvt046  0.226
2019 Wiedmann F, Kiper AK, Bedoya M, Ratte A, Rinné S, Kraft M, Waibel M, Anad P, Wenzel W, González W, Katus HA, Decher N, Schmidt C. Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 52: 1223-1235. PMID 31001961 DOI: 10.33594/000000083  0.22
2013 Jehle J, Ficker E, Wan X, Deschenes I, Kisselbach J, Wiedmann F, Staudacher I, Schmidt C, Schweizer PA, Becker R, Katus HA, Thomas D. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. British Journal of Pharmacology. 168: 1215-29. PMID 23061993 DOI: 10.1111/Bph.12002  0.203
2013 Schmidt C, Wiedmann F, Schweizer PA, Becker R, Katus HA, Thomas D. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels. European Journal of Pharmacology. 721: 237-48. PMID 24070813 DOI: 10.1016/j.ejphar.2013.09.029  0.202
2018 Schmidt C, Peyronnet R. Voltage-gated and stretch-activated potassium channels in the human heart : Pathophysiological and clinical significance. Herzschrittmachertherapie & Elektrophysiologie. PMID 29305705 DOI: 10.1007/s00399-017-0541-z  0.196
2019 Wiedmann F, Schlund D, Voigt N, Ratte A, Kraft M, Katus HA, Schmidt C. N-glycosylation-dependent regulation of hK17.1 currents. Molecular Biology of the Cell. mbcE18100687. PMID 30969900 DOI: 10.1091/mbc.E18-10-0687  0.181
2018 Schmidt C, Wiedmann F, Beyersdorf C, Zhao Z, El-Battrawy I, Li X, Lang S, Rapti K, Jungmann A, Mueller O, Zhou X, Borggrefe M, Katus H, Thomas D. 197Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model European Heart Journal. 39. DOI: 10.1093/eurheartj/ehy564.197  0.176
2023 Grammatika Pavlidou N, Dobrev S, Beneke K, Reinhardt F, Pecha S, Jacquet E, Abu-Taha IH, Schmidt C, Voigt N, Kamler M, Schnabel RB, Baczkó I, Garnier A, Reichenspurner H, Nikolaev VO, et al. Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism. European Heart Journal. PMID 36810794 DOI: 10.1093/eurheartj/ehad086  0.175
2021 Sasipong N, Schlegel P, Wingert J, Lederer C, Meinhardt E, Ziefer A, Schmidt C, Rapti K, Thöni C, Frey N, Most P, Katus HA, Raake PWJ. Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33839322 DOI: 10.1016/j.ymthe.2021.04.010  0.17
2019 Wiedmann F, Schlund D, Faustino F, Kraft M, Ratte A, Thomas D, Katus HA, Schmidt C. -Glycosylation of TREK-1/hK2.1 Two-Pore-Domain Potassium (K) Channels. International Journal of Molecular Sciences. 20. PMID 31635148 DOI: 10.3390/ijms20205193  0.169
2014 Rahm AK, Wiedmann F, Gierten J, Schmidt C, Schweizer PA, Becker R, Katus HA, Thomas D. Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channels. Naunyn-Schmiedeberg's Archives of Pharmacology. 387: 291-300. PMID 24311292 DOI: 10.1007/s00210-013-0945-1  0.167
2017 Rinné S, Kiper AK, Schmidt C, Ortiz-Bonnin B, Zwiener S, Seebohm G, Decher N. Stress-Kinase Regulation of TASK-1 and TASK-3. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 44: 1024-1037. PMID 29179200 DOI: 10.1159/000485402  0.167
2022 Wahl CM, Schmidt C, Hecker M, Ullrich ND. Distress-Mediated Remodeling of Cardiac Connexin-43 in a Novel Cell Model for Arrhythmogenic Heart Diseases. International Journal of Molecular Sciences. 23. PMID 36077591 DOI: 10.3390/ijms231710174  0.166
2019 Wiedmann F, Schlund D, Ratte A, Katus HA, Kraft M, Thomas D, Schmidt C. P1601N-glycosylation of TREK-1/hK2P2.1 two-pore-domain (K2P) potassium channels European Heart Journal. 40. DOI: 10.1093/eurheartj/ehz748.0360  0.164
2018 El-Battrawy I, Zhao Z, Lan H, Li X, Yücel G, Lang S, Sattler K, Schünemann JD, Zimmermann WH, Cyganek L, Utikal J, Wieland T, Bieback K, Bauer R, Ratte A, ... ... Schmidt C, et al. Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy. Circulation. Genomic and Precision Medicine. 11: e001893. PMID 29545480 DOI: 10.1161/CIRCGEN.117.001893  0.163
2023 Heun F, Niebuhr T, Gutierrez Bautista A, Wiedmann F, Verhaar N, Kästner S, Feige K, Schmidt C. Treatment of a Paroxysmal Atrioventricular Block by Implantation of a Bipolar, Single-Chamber Cardiac Pacemaker in a Donkey. Animals : An Open Access Journal From Mdpi. 13. PMID 37684988 DOI: 10.3390/ani13172724  0.154
2020 Schmidt C, Ravens U. Genetic background of atrial fibrillation: influence of single-nucleotide polymorphisms. Cardiovascular Research. 116: e106-e108. PMID 32623450 DOI: 10.1093/Cvr/Cvaa166  0.137
2022 Wiedmann F, Ince H, Stellbrink C, Kleemann T, Eckardt L, Brachmann J, Gonska BD, Kääb S, Perings CA, Jung W, Lugenbiel P, Hochadel M, Senges J, Frey N, Schmidt C. Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy defibrillator patients - insights from the German DEVICE-registry. Heart Rhythm. PMID 36509321 DOI: 10.1016/j.hrthm.2022.12.009  0.121
2020 Bailey AL, Dmytrenko O, Greenberg L, Bredemeyer AL, Ma P, Liu J, Penna V, Lai L, Winkler ES, Sviben S, Brooks E, Nair AP, Heck KA, Rali AS, Simpson L, ... ... Schmidt C, et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. Biorxiv : the Preprint Server For Biology. PMID 33173875 DOI: 10.1101/2020.11.04.364315  0.12
2024 Hegner P, Schuh M, Wiedmann F, Camboni D, Schmid C, Maier LS, Schmidt C, Wagner S. Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesis. Heart Rhythm. PMID 38574786 DOI: 10.1016/j.hrthm.2024.03.1809  0.12
2024 Wiedmann F, Schmidt C. Novel drug therapies for atrial fibrillation. Nature Reviews. Cardiology. PMID 38418746 DOI: 10.1038/s41569-024-01004-2  0.12
2018 Brandenburg S, Pawlowitz J, Fakuade FE, Kownatzki-Danger D, Kohl T, Mitronova GY, Scardigli M, Neef J, Schmidt C, Wiedmann F, Pavone FS, Sacconi L, Kutschka I, Sossalla S, Moser T, et al. Axial Tubule Junctions Activate Atrial Ca Release Across Species. Frontiers in Physiology. 9: 1227. PMID 30349482 DOI: 10.3389/Fphys.2018.01227  0.106
2021 Bailey AL, Dmytrenko O, Greenberg L, Bredemeyer AL, Ma P, Liu J, Penna V, Winkler ES, Sviben S, Brooks E, Nair AP, Heck KA, Rali AS, Simpson L, Saririan M, ... ... Schmidt C, et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. Jacc. Basic to Translational Science. PMID 33681537 DOI: 10.1016/j.jacbts.2021.01.002  0.102
2014 Zarbock A, Meersch M, Schmidt C, Martens S, Rossaint J, Singbartl K, Görlich D, Kellum J, Van Aken H. Urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery Critical Care. 18: P381. DOI: 10.1186/cc13571  0.095
2022 Wiedmann F, De Simone R, Rose P, Karck M, Gorenflo M, Frey N, Schmidt C. Case report of an S-ICD implantation for secondary prevention in a patient with complex congenital heart disease, dextrocardia, and situs solitus. European Heart Journal. Case Reports. 6: ytac253. PMID 35821967 DOI: 10.1093/ehjcr/ytac253  0.094
2022 Kraft M, Foerster KI, Wiedmann F, Sauter M, Paasche A, Blochberger PL, Yesilgöz B, L'hoste Y, Frey N, Haefeli WE, Burhenne J, Schmidt C. Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue. Pharmaceutics. 14. PMID 35456597 DOI: 10.3390/pharmaceutics14040762  0.087
2018 Schmidt C, Wiedmann F, El-Battrawy I, Fritz M, Ratte A, Beller CJ, Lang S, Rudic B, Schimpf R, Akin I, Karck M, Borggrefe M, Katus HA, Zhou XB, Thomas D. Reduced Na Current in Native Cardiomyocytes of a Brugada Syndrome Patient Associated With β-2-Syntrophin Mutation. Circulation. Genomic and Precision Medicine. 11: e002263. PMID 30571189 DOI: 10.1161/CIRCGEN.118.002263  0.078
2023 Perino AC, Wang PJ, Lloyd M, Zanon F, Fujiu K, Osman F, Briongos-Figuero S, Sato T, Aksu T, Jastrzebski M, Sideris S, Rao P, Boczar K, Yuan-Ning X, Wu M, ... ... Schmidt C, et al. Worldwide survey on implantation of and outcomes for conduction system pacing with His bundle and left bundle branch area pacing leads. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. PMID 36607529 DOI: 10.1007/s10840-022-01417-4  0.074
2019 Schmidt C, Katus HA. Scientists on the Spot: Moving forward from myocardial injury. Cardiovascular Research. PMID 31800014 DOI: 10.1093/cvr/cvz297  0.068
1995 Schmidt C, Bellingham MC, Richter DW. Adenosinergic modulation of respiratory neurones and hypoxic responses in the anaesthetized cat. The Journal of Physiology. 483: 769-81. PMID 7776257 DOI: 10.1113/Jphysiol.1995.Sp020621  0.065
2012 Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA. Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients. Drug Design, Development and Therapy. 6: 289-95. PMID 23091373 DOI: 10.2147/DDDT.S36578  0.061
2010 Freilinger T, Ackl N, Ebert A, Schmidt C, Rautenstrauss B, Dichgans M, Danek A. A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline. Journal of the Neurological Sciences. 300: 160-3. PMID 21035146 DOI: 10.1016/j.jns.2010.09.032  0.061
2017 Schmidt C, Wiedmann F, El-Battrawy I, Fritz M, Ratte A, Lang S, Rudic B, Karck M, Borggrefe M, Katus H, Zhou X, Thomas D. P5835Characterization of a novel genetic variant associated with Brugada syndrome: beta-2-syntrophin mutation impairs interaction with SCN5A and reduces Na+ current in human cardiomyocytes European Heart Journal. 38. DOI: 10.1093/eurheartj/ehx493.P5835  0.058
2015 Schmidt C. Eine schöne Bescherung und andere Vorfälle Jura - Juristische Ausbildung. 37. DOI: 10.1515/jura-2015-0021  0.035
2018 Schmidt C, Hubbard T. Scientists on the Spot: Sequencing the human genome to influence patient healthcare. Cardiovascular Research. 114: e66-e67. PMID 30052801 DOI: 10.1093/cvr/cvy133  0.034
2018 Schmidt C, Hubbard T. Scientists on the Spot: Sequencing the human genome to influence patient healthcare. Cardiovascular Research. 114: e66-e67. PMID 30052801 DOI: 10.1093/cvr/cvy133  0.034
1988 Huber-Spitzy V, Arocker W, Schmidt C. [Ophthalmia neonatorum]. Klinische Monatsblatter Fur Augenheilkunde. 191: 341-3. PMID 3430999 DOI: 10.1055/s-2008-1050522  0.03
2014 Schmidt C, Radermacher L. Rückzahlung von arbeitgeberseitig verauslagten Fortbildungskosten Monatsschrift FüR Deutsches Recht. 68: 316-321. DOI: 10.9785/ovs.mdr.2014.0606  0.028
2014 Schmidt C, Radermacher L. Rückzahlung von arbeitgeberseitig verauslagten Fortbildungskosten Monatsschrift FüR Deutsches Recht. 68. DOI: 10.9785/mdtr-2014-0606  0.028
2018 Schmidt C. Single-cell transcriptomics in embryology: implications for cardiovascular science. Cardiovascular Research. 114: e87-e88. PMID 31346599 DOI: 10.1093/cvr/cvy193  0.023
2016 Schmidt C, Bassemir J. Einmal hin, Arzt ist drin Jura - Juristische Ausbildung. 2016. DOI: 10.1515/jura-2016-0258  0.013
2019 Schmidt C. A new method to study membrane protein complexes by mass spectrometry. Cardiovascular Research. PMID 31089690 DOI: 10.1093/cvr/cvz113  0.012
2020 Schmidt C, Bollini S. ESC Congress 2020, the digital experience: a report from the ESC Scientists of Tomorrow. Cardiovascular Research. 116: e190-e192. PMID 33096565 DOI: 10.1093/cvr/cvaa278  0.01
2020 Schmidt C, Voigt N. Insights into latest cardiovascular research at scientific institutions in Göttingen and Heidelberg: a report by the ESC Scientists of Tomorrow. Cardiovascular Research. PMID 32754726 DOI: 10.1093/cvr/cvaa165  0.01
2020 Schmidt C, Voigt N. Insights into latest cardiovascular research at scientific institutions in Göttingen and Heidelberg: a report by the ESC Scientists of Tomorrow. Cardiovascular Research. PMID 32754726 DOI: 10.1093/cvr/cvaa165  0.01
2018 Schmidt C, Voigt N. ESC Congress 2018 highlights in basic science: a report from the Scientists of Tomorrow. Cardiovascular Research. 114: e103-e105. PMID 30351376 DOI: 10.1093/cvr/cvy234  0.01
2012 Peterek M, Schmidt C. Palliative Einrichtungen als Lebensraum und Sterbeorte – Musik, Fotos und Texte aus dem Alltag eines stationären Hospizes Zeitschrift FüR Palliativmedizin. 13. DOI: 10.1055/s-0032-1322942  0.01
2011 Marksteiner-Fuchs P, Schmidt C, Ertelthalner A. Gesundheitsförderung bei arbeitslosen Jugendlichen - Fit für den Ersten Arbeitsmarkt Ergopraxis. 4: 8-10. DOI: 10.1055/s-0031-1274913  0.01
Hide low-probability matches.